Historical

Ongoing Disclosure Notice - A. Clarke

12:17pm, 31 Jan 2012 | RELINT

Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988

A Details of director or officer

Name of director or officer of public issuer: Alan William CLARKE
Name of public issuer: Abano Healthcare Group Limited
Name of related body corporate (if applicable): N/A
Position held in public issuer: Managing Director

B Securities in public issuer or related body corporate to which this disclosure relates

Number, class, and type of securities:
(a) 5,900 ordinary shares
(b) 66 ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities:
(a)Registered holder and beneficial owner
(b)Registered holder and discretionary beneficiary of the Clarke Family Trust

Name of registered holder of those securities
(a) Alan William CLARKE
(b) Alan William CLARKE, Margaret Clare ADAMS and Christopher David ROSS as Trustees of The Clarke Family Trust

D Details of acquisitions and disposals
If the relevant interest was acquired—
Date of acquisition: 27 January 2012
Consideration paid for acquisition: $4.04 per share

If the relevant interest was disposed of—
Date of disposal: N/a
Consideration received for disposal: N/a

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Issue of shares pursuant to participation in the Dividend Reinvestment Plan for the 2012 interim dividend

E Total number of transactions this notice relates to: Two

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 5 December 2011

Date of signature: 31 January 2012